SEC Contract Filing

Filing Date: 2022-02-16

Document Content:
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>axim_ex10z3.htm
<DESCRIPTION>6% CONVERTIBLE REDEEMABLE NOTE DATED SEPTEMBER 29, 2021, MADE BY AND BETWEEN AXIM BIOTECHNOLOGIES, INC. AND GS CAPITAL PARTNERS, LLC, AS AMENDED
<TEXT>
<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2022 [PPXK5GW761L0VFNE7HJL]. www.edgarsuite.com -->
<HEAD>
</HEAD>
<BODY>
<DIV style=margin-left:73pt;width:471pt><P align=justify style='font:11pt Times New Roman;margin-top:4.55pt;margin-bottom:0pt;text-indent:0.7pt;margin-left:72pt;margin-right:72pt'><FONT style=color:#343434><B>THIS</B><B> </B><B>NOTE</B><B> </B><B>AND</B><B> </B><B>THE</B><B> </B><B>COMMON</B><B> </B><B>STOCK</B><B> </B><B>ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN</B><B> </B><B>AND</B><B> </B><B>WILL</B><B> </B><B>NOT</B><B> </B><B>BE</B><B> </B><B>REGISTERED WITH</B><B> </B><B>THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION</B><B> </B><B>OR</B><B> </B><B>THE</B><B> </B><B>SECURITIES</B><B> </B><B>COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE </B><B>&#8220;</B><B>1933</B><B> </B><B>ACT</B><B>&#8221;</B><B>)</B></FONT></P>
<P style='font:12pt Times New Roman;margin:0'>&nbsp;</P>
<P align=right style='font:10pt Times New Roman;margin-top:8.65pt;margin-bottom:0pt'><FONT style=color:#343434><B>US</B><B> $1,110,000.00</B></FONT></P>
<P style='font:11.5pt Times New Roman;margin:0;color:#343434'>&nbsp;</P>
<P align=center style='font:11.5pt Times New Roman;margin:0'><FONT style=color:#343434>AXIM BIOTECHNOLOGIES, INC.</FONT></P>
<P align=center style='font:11.5pt Times New Roman;margin-top:0.25pt;margin-bottom:0pt'><FONT style=color:#343434>6% CONVERTIBLE REDEEMABLE NOTE </FONT><BR><FONT style=color:#343434>DUE SEPTEMBER 29, 2022</FONT></P>
<P style='font:13pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin-top:0.45pt;margin-bottom:0pt'>&nbsp;</P>
<P align=justify style='font:11.5pt Times New Roman;margin:0;text-indent:36pt'><FONT style=color:#343434>FOR VALUE RECEIVED, AXIM BIOTECHNOLOGIES, INC. (the &#8220;Company'') promises to pay to the order of GS CAPITAL PARTNERS, LLC and its authorized successors and permitted assigns (&#8220;</FONT><FONT style='color:#343434;border-bottom:1px solid #343434'>Holder</FONT><FONT style=color:#343434>&#8221;), the aggregate principal face amount of One Million One Hundred Ten Thousand Dollars exactly (U.S. $1,110,000.00) on SEPTEMBER 29, 2022 (&#8220;</FONT><FONT style='color:#343434;border-bottom:1px solid #343434'>Maturity Date</FONT><FONT style=color:#343434>&#8221;) and to pay interest on the principal amount outstanding hereunder at the rate of 6% per annum commencing on SEPTEMBER 29, 2021 (&#8220;</FONT><FONT style='color:#343434;border-bottom:1px solid #343434'>Issuance Date</FONT><FONT style=color:#343434>&#8221;). This Note shall contain an original issue discount of $100,000.00 such that the purchase price is $1,010,000.00. The interest will be paid to the Holder in whose name this Note is registered on the records of the Company regarding registration and transfers of this Note. The principal of, and interest on, this Note are payable at 30 Washington Street, Suite 5L, Brooklyn, NY 11201, initially, and if changed, last appearing on the records of the Company as designated in writing by the Holder hereof from time to time. The Company will pay each interest payment and the outstanding principal due upon this Note before or on the Maturity Date, less any amounts required by law to be deducted or withheld, to the Holder of this Note by check or wire transfer addressed to such Holder at the last address appearing on the records of the Company. The forwarding of such check or wire transfer shall constitute a payment of outstanding principal hereunder and shall satisfy and discharge the liability for principal on this Note to the extent of the sum represented by such check or wire transfer. Interest shall be payable in Common Stock (as defined below) pursuant to paragraph 4(b) herein.</FONT></P>
<P style='font:11pt Times New Roman;margin-top:0.1pt;margin-bottom:0pt'>&nbsp;</P>
<P style='font:11.5pt Times New Roman;margin:0;text-indent:36pt'><FONT style=color:#343434>This Note is subject to the following additional provisions:</FONT></P>
<P style='font:11.5pt Times New Roman;margin-top:0.2pt;margin-bottom:0pt'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin-top:4.55pt;margin-bottom:0pt;text-indent:36pt'>1. <FONT style=font-size:11.5pt;color:#343434>This Note is exchangeable for an equal aggregate principal amount of Notes </FONT><FONT style=color:#343434>of different authorized denominations, as requested by the Holder surrendering the same. No service charge will be made for such registration or transfer or exchange, except that Holder shall pay any tax or other governmental charges payable in connection therewith.</FONT></P>
<P style='font:11.5pt Times New Roman;margin-top:0.3pt;margin-bottom:0pt'>&nbsp;</P>
<P align=justify style='font:11pt Times New Roman;margin-top:4.55pt;margin-bottom:0pt;text-indent:36pt;color:#343434'>2. The Company shall be entitled to withhold from all payments any amounts required to be withheld under applicable laws.</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P align=center style='font:11pt Times New Roman;margin:0'>1</P>
<P style='font:11pt Times New Roman;margin:0'>______</P>
<P style='font:11pt Times New Roman;margin:0'>Initials</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P align=justify style='font:11pt Times New Roman;margin-top:4.55pt;margin-bottom:0pt;text-indent:36pt;color:#343434'>3. This Note may be transferred or exchanged only in compliance with the Securities Act of 1933, as amended (&#8220;<FONT style='border-b